聯化科技(002250.SZ):台州聯化通過美國FDA現場檢查
格隆匯9月15日丨聯化科技(002250.SZ)公佈,公司的子公司聯化科技(台州)有限公司(簡稱“台州聯化”)於2023年7月31日至2023年8月4日接受了美國食品藥品監督管理局(簡稱“美國FDA”)為期五天的cGMP現場檢查。該現場檢查是由2個API及1個高級中間體引發的GMP監督檢查和註冊批准前檢查。台州聯化近日收到了美國FDA針對這次檢查的現場檢查報吿(EIR),報吿檢查結果為0-483(零缺陷)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.